000 01564 a2200469 4500
005 20250516160212.0
264 0 _c20150417
008 201504s 0 0 eng d
022 _a1520-5762
024 7 _a10.3109/03639045.2013.810636
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aParveen, Rabea
245 0 0 _aSolid lipid nanoparticles of anticancer drug andrographolide: formulation, in vitro and in vivo studies.
_h[electronic resource]
260 _bDrug development and industrial pharmacy
_cSep 2014
300 _a1206-12 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAnimals
650 0 4 _aAntineoplastic Agents
_xchemistry
650 0 4 _aArea Under Curve
650 0 4 _aBiological Availability
650 0 4 _aCell Line, Tumor
650 0 4 _aChemistry, Pharmaceutical
_xmethods
650 0 4 _aDiterpenes
_xchemistry
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aLipids
_xchemistry
650 0 4 _aMCF-7 Cells
650 0 4 _aMice
650 0 4 _aMice, Inbred BALB C
650 0 4 _aNanoparticles
_xchemistry
650 0 4 _aParticle Size
650 0 4 _aSolubility
650 0 4 _aSolvents
_xchemistry
650 0 4 _aSuspensions
_xchemistry
650 0 4 _aWater
_xchemistry
700 1 _aAhmad, F J
700 1 _aIqbal, Z
700 1 _aSamim, M
700 1 _aAhmad, Sayeed
773 0 _tDrug development and industrial pharmacy
_gvol. 40
_gno. 9
_gp. 1206-12
856 4 0 _uhttps://doi.org/10.3109/03639045.2013.810636
_zAvailable from publisher's website
999 _c22891796
_d22891796